Table 2. IGF1 (CA)n microsatellite genotype frequencies among healthy postmenopausal women tested for plasma IGF1 level by racial/ethnic group.
| African American | Japanese American | Non-Latino White | Latino American | |
|---|---|---|---|---|
| Genotypea | N (%) | N (%) | N (%) | N (%) |
| 23/17 | 0 (0) | 1 (2) | 0 (0) | 0 (0) |
| 22/19 | 1 (1.5) | 0 (0) | 3 (6.4) | 1 (1.5) |
| 21/21 | 2 (3.0) | 2 (4.0) | 0 (0) | 2 (2.9) |
| 21/20 | 1 (1.5) | 4 (8.0) | 1 (2.1) | 3 (4.4) |
| 21/19 | 8 (12.3) | 12 (24.0) | 5 (10.6) | 11 (16.2) |
| 21/18 | 3 (4.6) | 5 (10.0) | 0 (0) | 2 (2.9) |
| 21/17 | 1 (1.5) | 2 (4.0) | 1 (2.1) | 0 (0) |
| 21/16 | 1 (1.5) | 0 (0) | 0 (0) | 0 (0) |
| 20/20 | 3 (4.6) | 0 (0) | 1 (2.1) | 2 (2.9) |
| 20/19 | 7 (10.8) | 8 (16.0) | 12 (25.5) | 14 (20.6) |
| 20/18 | 2 (3.1) | 0 (0) | 0 (0) | 1 (1.5) |
| 20/16 | 1 (1.5) | 0 (0) | 0 (0) | 0 (0) |
| 19/19 | 10 (15.4) | 5 (10.0) | 21 (44.7) | 29 (42.7) |
| 19/18 | 13 (20.0) | 3 (6.0) | 3 (6.4) | 2 (2.9) |
| 19/17 | 1 (1.5) | 6 (12.0) | 0 (0) | 1 (1.5) |
| 19/16 | 3 (4.6) | 0 (0) | 0 (0) | 0 (0) |
| 18/18 | 4 (6.2) | 2 (4.0) | 0 (0) | 0 (0) |
| 18/17 | 3 (4.6) | 0 (0) | 0 (0) | 0 (0) |
| 18/16 | 1 (1.5) | 0 (0) | 0 (0) | 0 (0) |
| Non-19/non-19 | 22 (33.9) | 16 (32.0) | 3 (6.4) | 10 (14.7) |
| Non-19/19 | 33 (50.8) | 29 (58.0) | 23 (48.9) | 29 (42.7) |
| 19/19 | 10 (15.4) | 5 (10.0) | 21 (44.7) | 29 (42.7) |
Number of (CA) repeats for the two alleles.